Shanghai Pharmaceuticals (02607) Releases January 2026 Monthly Return on Securities Movements

Bulletin Express02-03

Shanghai Pharmaceuticals Holding Co., Ltd. (02607) released the Monthly Return on Movements in Securities for the period ending January 31, 2026. The total authorised share capital remained RMB 3,708,361,809, with 919,072,704 H shares (par value of RMB 1) and 2,789,289,105 A shares (par value of RMB 1), showing no change from the previous month.

No adjustments occurred in the number of issued shares for either H shares or A shares. The public float requirement remained fully satisfied. No repurchases or redemptions of shares were recorded, and the treasury shares balance remained at zero.

The A share option scheme recorded 680,000 outstanding share options at an exercise price of RMB 20.16, with no new issuances or transfers during January 2026. All relevant listing rules and regulatory requirements were confirmed as duly met.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment